Business Wire

GSMA: 5G At Risk If Mobile Operators Don’t Get Access to the Right Spectrum

Jaa

The successful rollout of ultra-fast 5G services relies on timely access to the right amount and type of spectrum in the next year, warns the GSMA in an industry position released today. As the race to launch 5G services intensifies, the GSMA highlights the need for governments, regulators and the mobile industry to work together to deliver widespread coverage, and the full potential of 5G for everyone.

According to the ‘GSMA Public Policy Position on 5G Spectrum,’ governments around the world have started to auction spectrum for 5G networks, but variations in how much spectrum has been assigned, the onerous conditions imposed – and the cost of access to that spectrum – means the speed, reach and quality of 5G services could vary dramatically between countries. Early adopter countries will be the first to realise the significant benefits of 5G – from fibre-like mobile broadband speeds and smarter cities to autonomous cars and digitised factories – and stand to reap important socio-economic benefits including GDP growth. GSMA Intelligence forecasts that there will be 1.3 billion 5G connections by 2025, but this will be dependent on operators gaining access to sufficient spectrum.

“Operators urgently need more spectrum to deliver the endless array of services that 5G will enable - our 5G future depends heavily on the decisions governments are making in the next year as we head into WRC-19,” said Brett Tarnutzer, Head of Spectrum, GSMA. “Without strong government support to allocate sufficient spectrum to next generation mobile services, it will be impossible to achieve the global scale that will make 5G affordable and accessible for everyone. There is a real opportunity for innovation from 5G, but this hinges on governments focusing on making enough spectrum available, not maximising auction revenues for short term gains.”

The GSMA outlines several key considerations for governments and regulators, including:

1. 5G needs wider frequency bands to support higher speeds and larger amounts of traffic. Regulators that make available 80-100 MHz of spectrum per operator in prime 5G mid-bands (e.g. 3.5 GHz) and around 1 GHz per operator in vital millimeter wave bands (i.e. above 24 GHz), will best support the very fastest 5G services.

2. 5G needs spectrum within three key frequency ranges to deliver widespread coverage and support all use cases:

  • Sub-1GHz spectrum to extend high-speed 5G mobile broadband coverage across urban, suburban and rural areas and to help support Internet of Things (IoT) services
  • Spectrum from 1-6 GHz to offer a good mix of coverage and capacity for 5G services
  • Spectrum above 6 GHz for 5G services such as ultra-high-speed mobile broadband

3. It is essential that governments support the 26 GHz, 40 GHz (37-43.5 GHz) and 66-71 GHz bands for mobile at WRC-19. A sufficient amount of harmonised 5G spectrum in these bands is critical to enabling the fastest 5G speeds, low-cost devices and international roaming and to minimising cross-border interference.

4. Governments and regulators should avoid inflating 5G spectrum prices (e.g. setting high auction reserve prices) as they risk limiting network investment and driving up the cost of services.

5. Regulators should avoid setting aside spectrum for verticals in key mobile spectrum bands; sharing approaches, such as leasing, are better options where vertical industries require access to spectrum.

“Governments and regulators have a major role to play in ensuring that consumers get the best outcome from 5G,” added Tarnutzer. “Once spectrum is allocated to mobile at WRC, licensing that spectrum at a national level, as history has shown, can take up to 10 years. Therefore, it is essential that governments take the right action now.”

The ‘GSMA Public Policy Position on 5G Spectrum’ is available here .

Further information on the GSMA’s position on WRC-19 can be viewed here .

-ENDS-

About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators with over 350 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.

For more information, please visit the GSMA corporate website at www.gsma.com. Follow the GSMA on Twitter: @GSMA.

Contact information

Media Contacts
For the GSMA
Alia Ilyas
+44 (0)7970 637622
ailyas@gsma.com
or
GSMA Press Office
pressoffice@gsma.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Knopp Biosciences Presents Positive Preclinical Data for Lead Neonatal Epilepsy Drug Candidate at 2019 Antiepileptic Drug and Device Trials XV Conference24.5.2019 17:00:00 EESTTiedote

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases of high unmet need, today presented in vitro and in vivo data for the company’s lead molecule for the targeted treatment of KCNQ2-neonatal epileptic encephalopathy (KCNQ2-NEE) at the Antiepileptic Drug and Device Trials XV Conference in Miami, Florida. KCNQ2-NEE, a rare infant genetic epilepsy, results from mutations in genes encoding the Kv7.2/Kv7.3 ion channel, leading to frequent seizures and profound developmental delay. The preclinical data were presented by Steven Dworetzky, Ph.D., Knopp’s Chief Scientific Officer, a longtime Kv7 researcher who led the group that first cloned the Kv7.2 and Kv7.3 genes during his former tenure with the Bristol-Myers Squibb Co. Dr. Dworetzky presented results demonstrating the in vitro nanomolar activity of KB-3061 and its significant seizure protection in the maximal electroshock mo

Accelerate Your Business in South Korea Through 2019 K-Startup Grand Challenge24.5.2019 13:20:00 EESTTiedote

Entrepreneurs from across the globe should set their sights on participating in the 2019 K-Startup Grand Challenge. Supported by the Ministry of SMEs and Startups and National IT Industry Promotion Agency (NIPA) of South Korea, the initiative provides invaluable support and comprehensive resources to early age startups. Applications for the K-Startup Grand Challenge are currently being accepted through June 14, 2019. In order to advance in the program, teams must pass a regional audition. A judging panel of startup ecosystem experts and Korean accelerators will select 40 teams to participate in an enriching 3.5 month-long acceleration program in Korea. The selected teams will have exclusive access to free office space at the Startup Campus in Pangyo Techno Valley, one-on-one mentoring, information sessions, coaching on Korean and Asian business culture and the chance to attend insightful seminars on accounting regulations to tax laws, patents and more. Opportunities for networking with

New Investigational Clinical Data for Ipsen’s Oncology Products in 11 Solid Tumor Types to Be Presented at 2019 ASCO Annual Meeting24.5.2019 08:00:00 EESTTiedote

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that new data from clinical studies on investigational uses of cancer medicines cabozantinib (Cabometyx®), liposomal irinotecan (Onivyde®), and lanreotide autogel (Somatuline®, marketed as Somatuline Depot® in the United States) will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting takes place in Chicago, Illinois, U.S., 31 May–4 June 2019; data featuring Ipsen medicines includes: New data from the Phase 3 CELESTIAL trial on the association of adverse events with efficacy outcomes for cabozantinib in patients with advanced hepatocellular carcinoma Overview of the Phase 3 COSMIC-312 trial of cabozantinib in combination with atezolizumab vs sorafenib in patients with advanced hepatocellular carcinoma who have not received previous systemic anticancer therapy First Phase 2 data from the CaboGIST study (trial 1317) from the European Organization for Research and Treatment of

The Posiflex Group Showcases an Ecosystem of Connected Solution Endpoints with IoT Remote Monitoring at Computex 201924.5.2019 04:00:00 EESTTiedote

For the Computex 2019 show, The Posiflex Group is featuring leading solution technology from the family of brands as a fully Serviced IoT Ecosystem. Solution end points include: Connected Modular Kiosks, POS Terminals, and Digital Signage solutions from Posiflex and KIOSK Information Systems Smart Medical Displays with gesture controls from Portwell Connected Gaming Solutions with Player Tracking Technology from Portwell subsidiary, Ganlot The booth display is based on common field service endpoints represented in a European Manor Destination Resort setting. Field solutions for an array of vertical market applications include QSR ordering, cinema ticketing, fashion retail customer loyalty, interactive signage, hotel / medical center check-in and bill pay, as well as casino gaming technology. This year, in addition to their renowned POS product suite, Posiflex will be featuring newly introduced Modular Kiosk platforms (co-designed by KIOSK and Posiflex), which are configure-to-order sta

Audi China President Thomas Owsianski to Keynote at CES Asia 201923.5.2019 23:00:00 EESTTiedote

The Consumer Technology Association (CTA)TM today announced that Thomas Owsianski, president of Audi China, will deliver a keynote address at the upcoming CES Asia 2019. Now in its fifth year, CES Asia will run June 11-13, 2019 at the Shanghai New International Expo Centre (SNIEC) in Shanghai, China. Thomas Owsianski’s keynote is scheduled for 4 PM, Tuesday, June 11, where he will unveil Audi’s vision in transforming mobility from a driving experience to a digital adventure. Mr. Owsianski joined the top management team of Audi China in August 2018 and was named President in October 2018. “Audi has been at the forefront of driving global transformation in the automotive industry through their breakthrough advancements in technology,” said Karen Chupka, executive vice president, CES. “Innovation has revolutionized the transportation experience, and we welcome Mr. Owsianski to the CES Asia stage to share Audi’s vision for the future of global mobility.” Throughout Asia and beyond, technol

ITechLaw Publishes New Book and Opens Global Public Comment Period on Draft Principles for Responsible Artificial Intelligence23.5.2019 22:11:00 EESTTiedote

The International Technology Law Association (ITechLaw) has published Responsible AI: A Global Policy Framework, a new book that provides an in-depth review and eight discussion principles that address some of the hottest technology and moral issues of responsible development, deployment and use of artificial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190523005752/en/ ITechLaw releases new book, Responsible AI: A Global Policy Framework, and opens public comment period. (Photo: Business Wire) Written by a multi-disciplinary group of 54 technology law experts, industry representatives and researchers from 16 countries, the book offers an actionable framework built on the following principles: Ethical Purpose and Societal Benefit, Accountability, Transparency and Explainability, Fairness and Non-discrimination, Safety and Reliability, Open Data and Fair Competition, Privacy, and AI and Intellectual Property.

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme